All stages of the research were performed after obtaining informed written consent from the parents and the verbal consent of the child and based on the latest version of Helsinki Declaration. Topiramate,
Conditions
Interventions
In TPM group,
participants were received esca-
lating doses. In addition,
contingency manage-
ment was provided for twelve weeks. All sub-
jects received brief behavioral compliance en-
hancement treatment (BBCET). ,contingency management was provided for twelve weeks,Mix group receive topiramate and contingency management
Experimental Drug,Experimental Behavioral,Experimental Other
Topiramate ,contingency management ,Mix group
Sponsors
none
Eligibility
Sex/Gender
Male
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria for participation in this study were: 1) having the respective age between 18 and 31, 2) History of one months of cocaine avoidance, and 3) having at least the educational level of Diploma.
Exclusion criteria
Exclusion criteria: Also the exclusion criteria were: 1) Report of positive urine test during remedial period, 2) Taking supplementary drug and psychological remedies, and 3) three continuous weeks of absence from participation in remedial meetings.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cocaine urine tests 8 weeks detection of benzoylecgonine | — |
Secondary
| Measure | Time frame |
|---|---|
| craving 8 weeks craving questionnaire | — |
Countries
iran
Contacts
Public Contactbijan pirnia
Bijan Center
Outcome results
None listed